Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Morpholine Market by Type (Purity 97%, Purity 98%, Purity 98.5%, Other), By Application (Chemical Reagents, Pharmaceutical Intermediates, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Morpholine Market by Type (Purity 97%, Purity 98%, Purity 98.5%, Other), By Application (Chemical Reagents, Pharmaceutical Intermediates, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 138944 3300 Pharma & Healthcare 377 238 Pages 4.7 (46)
                                          

The global morpholine market is expected to grow at a CAGR of 3.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for morpholine in chemical reagents and pharmaceutical intermediates applications. Morpholine is used as a solvent in chemical reactions and as an intermediate for pharmaceuticals such as acetaminophen, ibuprofen, and naproxen. Morpholine is also used in the production of other chemicals such as ethylmorphine, morphine, codeine, hydrocodone, oxycodone and hydromorphone. Morpholine Market By Application: Chemical Reagents (Purity 97%, Purity 98%), Pharmaceutical Intermediates (Purity 97%, Purity 98%). -The global market for Morpholine is expected to grow at a CAGR of 3.2% during the forecast period, 2016-2020. -The growth of the global Morpholine market is driven by factors such as increasing demand for pharmaceuticals and chemicals, growing population, and increasing awareness about health issues. -Increasing demand for pharmaceuticals and chemicals is one of the major drivers of the global Morpholine market. The use of Morpholine in pharmaceuticals has increased due to its ability to dissolve other substances in water or other liquids. This property makes it an ideal solvent for many chemical reactions that are used in drug manufacturing processes. The use of Morpholine as a solvent also helps reduce costs associated with production processes because it can be reused after being recovered from waste streams or recycled from products that have been used up or discarded.

Industry Growth Insights published a new data on “Morpholine Market”. The research report is titled “Morpholine Market research by Types (Purity 97%, Purity 98%, Purity 98.5%, Other), By Applications (Chemical Reagents, Pharmaceutical Intermediates, Other), By Players/Companies APL (IN), Anhui Haoyuan (CN), FUYUAN (CN), Liaoyuan (CN), Sinochem (CN), Huntsman (US), Basf (DE), Nippon Nyukazai (JP), Balaji Amines (IN)”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Morpholine Market Research Report

By Type

Purity 97%, Purity 98%, Purity 98.5%, Other

By Application

Chemical Reagents, Pharmaceutical Intermediates, Other

By Companies

APL (IN), Anhui Haoyuan (CN), FUYUAN (CN), Liaoyuan (CN), Sinochem (CN), Huntsman (US), Basf (DE), Nippon Nyukazai (JP), Balaji Amines (IN)

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

238

Number of Tables & Figures

167

Customization Available

Yes, the report can be customized as per your need.


Global Morpholine Industry Outlook


Global Morpholine Market Report Segments:

The global Morpholine market is segmented on the basis of:

Types

Purity 97%, Purity 98%, Purity 98.5%, Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Chemical Reagents, Pharmaceutical Intermediates, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. APL (IN)
  2. Anhui Haoyuan (CN)
  3. FUYUAN (CN)
  4. Liaoyuan (CN)
  5. Sinochem (CN)
  6. Huntsman (US)
  7. Basf (DE)
  8. Nippon Nyukazai (JP)
  9. Balaji Amines (IN)

Global Morpholine Market Overview


Highlights of The Morpholine Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Purity 97%
    2. Purity 98%
    3. Purity 98.5%
    4. Other
  1. By Application:

    1. Chemical Reagents
    2. Pharmaceutical Intermediates
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Morpholine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Morpholine Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Morpholine is a medication used to relieve pain. It is also used to treat seizures.

Some of the major players in the morpholine market are APL (IN), Anhui Haoyuan (CN), FUYUAN (CN), Liaoyuan (CN), Sinochem (CN), Huntsman (US), Basf (DE), Nippon Nyukazai (JP), Balaji Amines (IN).

The morpholine market is expected to register a CAGR of 3.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Morpholine Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Morpholine Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Morpholine Market - Supply Chain
   4.5. Global Morpholine Market Forecast
      4.5.1. Morpholine Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Morpholine Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Morpholine Market Absolute $ Opportunity

5. Global Morpholine Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Morpholine Market Size and Volume Forecast by Type
      5.3.1. Purity 97%
      5.3.2. Purity 98%
      5.3.3. Purity 98.5%
      5.3.4. Other
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Morpholine Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Morpholine Market Size and Volume Forecast by Application
      6.3.1. Chemical Reagents
      6.3.2. Pharmaceutical Intermediates
      6.3.3. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Morpholine Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Morpholine Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Morpholine Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Morpholine Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Morpholine Demand Share Forecast, 2019-2029

9. North America Morpholine Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Morpholine Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Morpholine Market Size and Volume Forecast by Application
      9.4.1. Chemical Reagents
      9.4.2. Pharmaceutical Intermediates
      9.4.3. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Morpholine Market Size and Volume Forecast by Type
      9.7.1. Purity 97%
      9.7.2. Purity 98%
      9.7.3. Purity 98.5%
      9.7.4. Other
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Morpholine Demand Share Forecast, 2019-2029

10. Latin America Morpholine Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Morpholine Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Morpholine Market Size and Volume Forecast by Application
      10.4.1. Chemical Reagents
      10.4.2. Pharmaceutical Intermediates
      10.4.3. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Morpholine Market Size and Volume Forecast by Type
      10.7.1. Purity 97%
      10.7.2. Purity 98%
      10.7.3. Purity 98.5%
      10.7.4. Other
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Morpholine Demand Share Forecast, 2019-2029

11. Europe Morpholine Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Morpholine Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Morpholine Market Size and Volume Forecast by Application
      11.4.1. Chemical Reagents
      11.4.2. Pharmaceutical Intermediates
      11.4.3. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Morpholine Market Size and Volume Forecast by Type
      11.7.1. Purity 97%
      11.7.2. Purity 98%
      11.7.3. Purity 98.5%
      11.7.4. Other
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potental Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Morpholine Demand Share, 2019-2029

12. Asia Pacific Morpholine Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Morpholine Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Morpholine Market Size and Volume Forecast by Application
      12.4.1. Chemical Reagents
      12.4.2. Pharmaceutical Intermediates
      12.4.3. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Morpholine Market Size and Volume Forecast by Type
      12.7.1. Purity 97%
      12.7.2. Purity 98%
      12.7.3. Purity 98.5%
      12.7.4. Other
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Morpholine Demand Share, 2019-2029

13. Middle East & Africa Morpholine Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Morpholine Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Morpholine Market Size and Volume Forecast by Application
      13.4.1. Chemical Reagents
      13.4.2. Pharmaceutical Intermediates
      13.4.3. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Morpholine Market Size and Volume Forecast by Type
      13.7.1. Purity 97%
      13.7.2. Purity 98%
      13.7.3. Purity 98.5%
      13.7.4. Other
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Morpholine Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Morpholine Market: Market Share Analysis
   14.2. Morpholine Distributors and Customers
   14.3. Morpholine Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. APL (IN)
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Anhui Haoyuan (CN)
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. FUYUAN (CN)
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Liaoyuan (CN)
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Sinochem (CN)
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Huntsman (US)
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Basf (DE)
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Nippon Nyukazai (JP)
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Balaji Amines (IN)
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us